Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Annals of Hematology|July 8, 2005
High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantationGesine Bug, Johannes Atta, Stefan A Klein, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2008
Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: a study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)Lothar Bergmann, Steiner Aamdal, Sandrine Marreaud, et al.
European Journal of Haematology|July 14, 2011
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemiaKai Uwe Chow, Soo-Zin Kim, Nils von Neuhoff, et al.
BMC Cancer|December 12, 2012
GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centersSylvia Hartmann, Claudio Agostinelli, Jürgen Diener, et al.
Experimental Hematology|September 13, 2002
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemiaJochen Greiner, Mark Ringhoffer, Masanori Taniguchi, et al.
Investigational New Drugs|April 13, 2011
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)Beate Schultheis, Dirk Strumberg, Lothar Bergmann, et al.
European Urology|September 10, 2013
Temsirolimus in daily use: results of a prospective multicentre noninterventional study of patients with metastatic kidney cancerAndres Jan Schrader, Sandra Seseke, Christian Keil, et al.
American Journal of Respiratory Cell and Molecular Biology|June 7, 2003
Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungsNorbert Weissmann, Nadine Ebert, Marit Ahrens, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2015
Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: results of a pooled analysis of non-interventional studiesLaurence Albiges, Ulrich Kube, Jean-Christophe Eymard, et al.
Leukemia & Lymphoma|July 7, 2007
The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell linesKai Uwe Chow, Daniel Nowak, Bettina Trepohl, et al.
Pageof 7